Skip to main content
SpringerLink
Log in

Patient and Physician Factors Contributing to Poor Outcomes in Patients with Asthma and COPD

  • Review Article
  • Published:
Disease Management & Health Outcomes

Abstract

Poor adherence with medical regimens by patients with asthma and chronic obstructive pulmonary disease (COPD) is a major problem facing medical practitioners, with patients typically taking approximately half the prescribed doses of self-administered medications. Poor adherence with medication regimens results in inadequate disease control and is assumed to be associated with poor long-term outcomes and high medical and social costs. Efforts to assist patients with treatment adherence are thought to improve the benefits of prescribed medications; however, even the most effective interventions do not necessarily lead to significant improvements in adherence and treatment outcomes.

Simple interventions (such as re-calling patients who miss appointments, making every effort to keep patients in care, and simplifying treatment regimens) and complex strategies (including combinations of more thorough patient instructions and counseling, reminders, close follow-up, supervised self-monitoring, family therapy, crisis intervention, and telephone follow-up) may improve adherence and treatment outcomes for both short- and long-term treatments. All these measures are highly dependent on a good physician-patient relationship, and the willingness and ability of caregivers to closely follow guidelines and recommendations.

The diversity and complexity of interventions, and uncertainty about their effects, make it difficult to assess which interventions are effective and which are not. The literature regarding interventions remains surprisingly limited. There is little evidence to show that medication adherence can be improved consistently, or that interventions will inevitably lead to improvements in treatment outcomes, especially considering the resources usually available in outpatient settings. Most studies assessing successful complex interventions have not assessed the effect on clinical endpoints. Studies in COPD are sparse compared with those in asthma, leaving room for further research efforts. As all self-administered treatments are affected by low adherence, and as the number of efficacious, self-administered treatments continues to grow, detailed knowledge about this complex issue may help to ensure better management in patients with obstructive pulmonary diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Fig. 1

Similar content being viewed by others

Notes

  1. The use of trade names is for product identification only and does not imply endorsement.

References

  1. Rabe KF, Schmidt DT. Pharmacological treatment of asthma today. Eur Respir J Suppl 2001; 34: 34s–40s

    Article  PubMed  CAS  Google Scholar 

  2. Beardon PHG, McGilchrist MM, McKendrick AD, et al. Primary non-compliance with prescribed medication in primary care. BMJ 1993; 307: 846–8

    Article  PubMed  CAS  Google Scholar 

  3. Cochrane GM. Therapeutic compliance in asthma: its magnitude and implications. Eur Respir J 1992; 5: 122–4

    PubMed  CAS  Google Scholar 

  4. Coutts JAP, Gibson NA, Paton JY. Measuring compliance with inhaled medication in asthma. Arch Dis Child 1992; 67(3): 332–3

    Article  PubMed  CAS  Google Scholar 

  5. Haynes RB, Taylor DW, Sacket DL. Compliance in health care. Baltimore (MD): Johns Hopkins University Press, 1979

    Google Scholar 

  6. Cramer JA, Bradley-Kennedy C, Scalera A. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease. Can Respir J 2007; 14: 25–9

    PubMed  Google Scholar 

  7. Tamura G, Ohta K. Adherence to treatment by patients with asthma or COPD: comparison between inhaled drugs and transdermal patch. Respir Med 2007; 101(9): 1895–902

    Article  PubMed  Google Scholar 

  8. Roghmann MC, Sexton M. Adherence to asthma guidelines in general practices. J Asthma 1999; 36: 381–7

    Article  PubMed  CAS  Google Scholar 

  9. Soriano JB, Rabe KF, Vermeire PA. Predictors of poor asthma control in European adults. J Asthma 2003; 40: 803–13

    Article  PubMed  Google Scholar 

  10. National Institutes of Health. Global strategy for asthma management and prevention: NHLBI/WHO workshop report. Bethesda (MD): US Department of Health and Human Services, 2006

    Google Scholar 

  11. Gillissen A. Managing asthma in the real world. Int J Clin Pract 2004; 58: 592–603

    Article  PubMed  CAS  Google Scholar 

  12. Suissa S, Ernst P, Benayoun S, et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000; 343: 332–6

    Article  PubMed  CAS  Google Scholar 

  13. Weiner P, Weiner M, Azgad Y. Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma. Thorax 1995; 50: 1270–3

    Article  PubMed  CAS  Google Scholar 

  14. Suissa S, Hemmelgarn B, Biais L, et al. Bronchodilators and acute cardiac death. Am J Respir Crit Care Med 1996; 154: 1598–602

    PubMed  CAS  Google Scholar 

  15. Spitzer WO, Suissa S, Ernst P, et al. The use of β-agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326: 501–6

    Article  PubMed  CAS  Google Scholar 

  16. Nelson HS, Weiss ST, Bleeker ER, et al. The salmeterol mulicenter asthma research trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006; 129: 15–26

    Article  PubMed  CAS  Google Scholar 

  17. Maneechotesuwan K, Essilfie-Quaye S, Kharitonov SA, et al. Loss of control of asthma following inhaled corticosteroid withdrawal is associated with increased sputum interleukin-8 and neutrophils. Chest 2007; 132: 98–105

    Article  PubMed  CAS  Google Scholar 

  18. Calverley PMA, Anderson JA, Celli BR, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775–89

    Article  PubMed  CAS  Google Scholar 

  19. Vestbo J, Pauwels RA, Anderson JA, et al. Early onset of effect of salmeterol and fluticasone Propionate in chronic obstructive pulmonary disease. Thorax 2005; 60: 301–4

    Article  PubMed  CAS  Google Scholar 

  20. Calverley PMA, Olsson H. Budesonide/formoterol in a single inhaler sustains improvements in lung function over 12 months compared with monocomponents and placebo in patients with COPD [abstract]. Am J Respir Crit Care Med 2003; 167: A319

    Article  Google Scholar 

  21. Jones PW, Willits LR, Burge PS, et al. Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations. Eur Respir J 2003; 21: 68–73

    Article  PubMed  CAS  Google Scholar 

  22. Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; I: 681–6

    Google Scholar 

  23. Elliott RA, Barber N, Horne R. Cost-effectiveness of adherence-enhancing interventions: a quality assessment of the evidence. Ann Pharmacother 2005; 39: 508–15

    Article  PubMed  Google Scholar 

  24. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996; 348: 383–6

    Article  PubMed  CAS  Google Scholar 

  25. GOLD Executive Committee. Global initiative for chronic obstructive lung disease [online]. Available from URL: http://www.goldcopd.com [Accessed 2007 1 Nov]

  26. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006; 368: 804–13

    Article  PubMed  CAS  Google Scholar 

  27. Lemanske RF, Busse WW. Asthma. JAMA 1997; 278: 1855–73

    Article  PubMed  Google Scholar 

  28. Lange P, Scharling H, Ulrik CS, et al. Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax 2006; 61: 100–4

    Article  PubMed  CAS  Google Scholar 

  29. Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339: 1194–200

    Article  PubMed  CAS  Google Scholar 

  30. Busse WW, Brazinsky S, Jacobson K, et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J Allergy Clin Immunol 1999; 104: 1215–22

    Article  PubMed  CAS  Google Scholar 

  31. Busse WW. Inflammation in asthma: the cornerstone of the disease and target of therapy. J Allergy Clin Immunol 1998; 102: S17–22

    Article  PubMed  CAS  Google Scholar 

  32. Hackett TL, Knight DA. The role of epithelial injury and repair in the origins of asthma. Curr Opin Allerg Clin Immunol 2007; 7: 63–8

    Article  Google Scholar 

  33. Larj MJ, Bleeker ER. Therapeutic responses in asthma and COPD: corticosteroids. Chest 2004; 126: 138S–49S

    Article  PubMed  CAS  Google Scholar 

  34. Bateman ED, Bousquet J, Keech ML, et al. The correlation between asthma control and health status: the GOAL study. Eur Respir J 2007; 29: 56–63

    Article  PubMed  CAS  Google Scholar 

  35. Bateman ED, Jacques L, Goldfrad C, et al. Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down. J Allergy Clin Immunol 2006; 117: 563–70

    Article  PubMed  CAS  Google Scholar 

  36. Mannino DM, Watt G, Hole D, et al. The natural history of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 627–43

    Article  PubMed  CAS  Google Scholar 

  37. Anthonisen NR. Prognosis in chronic obstructive pulmonary disease: results from multicenter clinical trials. Am Rev Respir Dis 1989; 140: 95–9

    Article  Google Scholar 

  38. Fletcher C, Peto R. The natural history of chronic airway obstruction. BMJ 1977; 1: 1645–8

    Article  PubMed  CAS  Google Scholar 

  39. Teramoto S. COPD pathogenesis from the viewpoint of risk factors. Intern Med 2007; 46: 77–9

    Article  PubMed  Google Scholar 

  40. Siafakas NM, Tzortzaki EG. Few smokers develop COPD: why? Respir Med 2002; 96: 615–24

    Article  PubMed  CAS  Google Scholar 

  41. Sandford AJ, Silverman EK. Chronic obstructive pulmonary disease: 1. Susceptibility factors for COPD the genotype-environment interaction. Thorax 2002 Aug; 57(8): 736–41

    Article  PubMed  CAS  Google Scholar 

  42. Stoller JK, Aboussouan LS. Alpha-1-antitrypsin deficiency. Lancet 2005; 365(9478): 2225–36

    Article  PubMed  CAS  Google Scholar 

  43. Mannino DM. COPD epidemiology, prevalence, morbidity and mortality, and disease heterogenity. Chest 2002; 121: 121–126S

    Article  Google Scholar 

  44. Gross NJ. Outcome measurements in COPD: are we schizophrenic? Chest 2003; 123: 1325–7

    Article  PubMed  Google Scholar 

  45. Belman MJ, Brooks LR, Ross DJ, et al. Variability of breathlessness measurement in patients with chronic obstructive pulmonary disease. Chest 1991; 99(3): 566–71

    Article  PubMed  CAS  Google Scholar 

  46. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54(7): 581–6

    Article  PubMed  CAS  Google Scholar 

  47. American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111–7

    Google Scholar 

  48. Wise RA, Brown CD. Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test. COPD 2005; 2(1): 125–9

    Article  PubMed  Google Scholar 

  49. Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002; 19: 398–404

    Article  PubMed  CAS  Google Scholar 

  50. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622–9

    PubMed  CAS  Google Scholar 

  51. Guyatt GH, Berman LB, Townsend M, et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42: 773–8

    Article  PubMed  CAS  Google Scholar 

  52. Calverley PMA. Minimal clinically important difference: exacerbations of COPD. COPD 2005; 2: 143–8

    Article  PubMed  Google Scholar 

  53. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. Ann Intern Med 1980; 93: 391–8

    Google Scholar 

  54. National Emphysema Treatment Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348: 2059–73

    Article  Google Scholar 

  55. Sin DD, Tu JV. Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 580–4

    PubMed  CAS  Google Scholar 

  56. Sin DD, Man SFP. Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter? Eur Respir J 2003; 21: 260–6

    Article  PubMed  CAS  Google Scholar 

  57. Gillissen A, Buhl R, Kardos P, et al. Inhalable corticosteroids in long-term COPD treatment: opinions of an expert panel [in German]. Pneumologie 2000; 54: 256–62

    Article  PubMed  CAS  Google Scholar 

  58. Suissa S. Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies. Am J Respir Crit Care Med 2003; 168: 49–53

    Article  PubMed  Google Scholar 

  59. Suissa S. Statistical treatment of exacerbations in therapeutic trials of COPD. Am J Respir Crit Care Med 2006; 173(8): 842–6

    Article  PubMed  Google Scholar 

  60. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005–12

    Article  PubMed  CAS  Google Scholar 

  61. Anthonisen NR, Connett JE, Enright PL, et al. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002; 166: 333–9

    Article  PubMed  Google Scholar 

  62. Hunter MH, King DE. COPD: management of acute exacerbations and chronic stable disease. Am Fam Physician 2001; 64: 603–12

    PubMed  CAS  Google Scholar 

  63. Scanlon PD, Connett JE, Waller LA, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: the Lung Health Study. Am J Respir Crit Care Med 2000; 161: 381–90

    PubMed  CAS  Google Scholar 

  64. American Lung Association. Chronic obstructive pulmonary disease (COPD): fact sheet [online]. Available from URL: http://www.lungusa.org/site/pp.asp?c=dvLUK9O0E&b=35020 [Accessed 2007 Jan 1]

  65. Burge PS, Calverley PMA, Jones PW, et al. Randomised, placebo-controlled study of fluticasone Propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000; 320: 1297–303

    Article  PubMed  CAS  Google Scholar 

  66. Soriano JB, Kiri VA, Pride NB, et al. Inhaled corticosteroids with/without longacting β-agonists reduce the risk of rehospitalization and death in COPD patients. Am J Respir Med 2003; 2: 67–74

    Article  PubMed  CAS  Google Scholar 

  67. Calverley PMA, Boonsawat W, Cseke Z, et al. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Respir J 2003; 22: 912–9

    Article  PubMed  CAS  Google Scholar 

  68. Burge PS, Calverley PMA, Jones PW, et al. Randomised, double blind, placebo controlled study of fluticasone Propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000; 320: 1297–303

    Article  PubMed  CAS  Google Scholar 

  69. Aaron SD, Vandernheen KL, Fergusson D, et al. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease. Ann Intern Med 2007; 146: 545–55

    PubMed  Google Scholar 

  70. Stempel DA, Stoloff SW, Carranza Rosenzweig JR, et al. Adherence to asthma Controller medication regimes. Respir Med 2005; 99: 1263–7

    Article  PubMed  CAS  Google Scholar 

  71. Williams LK, Pladevall M, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 2004; 114: 1288–93

    Article  PubMed  CAS  Google Scholar 

  72. Buston KM, Wood SF. Non-compliance amongst adolescents with asthma: listening to what they tell us about self-management. Fam Pract 2000; 17: 134–8

    Article  PubMed  CAS  Google Scholar 

  73. Rand CS, Nides M, Cowles MK, et al. Long-term metered-dose inhaler adherence in a clinical trial: the Lung Health Study Research Group. Am J Respir Crit Care Med 1995; 152: 580–8

    PubMed  CAS  Google Scholar 

  74. Dolce JJ, Chrisp C, Manzella B, et al. Medication adherence patterns in chronic obstructive pulmonary disease. Chest 1991; 99: 837–41

    Article  PubMed  CAS  Google Scholar 

  75. Adams RJ, Fuhlbrigge A, Guilbert T, et al. Inadequate use of asthma medication in the United States: results of the asthma in America national population survey. J Allergy Clin Immunol 2002; 110: 58–64

    Article  PubMed  Google Scholar 

  76. Fish JE, Lung CL. Adherence to asthma therapy. Ann Allergy Asthma Immunol 2001; 86: 24–30

    Article  PubMed  CAS  Google Scholar 

  77. Hernandez DV, Schmaling KB. Understanding and resolving adherence problems. Clin Rev Allergy Immunol 2004; 27: 65–73

    Article  PubMed  Google Scholar 

  78. Rand CS, Wise RA. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med 1994; 149: S69–76

    PubMed  CAS  Google Scholar 

  79. Cochrane GM, Home R, Chanez P. Compliance in asthma. Resp Med 1999; 93: 763–9

    Article  CAS  Google Scholar 

  80. Rau JL. Determinants of patient adherence to an aerosol regimen. Resp Care 2005; 50: 1346–56

    Google Scholar 

  81. Lagerlov P, Leseth A, Matheson I. The doctor-patient relationship and the management of asthma. Soc Sci Med 2000; 47: 85–91

    Article  Google Scholar 

  82. Bender B, Wamboldt FS, O’Connor SL, et al. Measurement of children’s asthma medication adherence by self report, mother report, canister weight, and Doser CT. Ann Allergy Asthma Immunol 2000; 85: 416–21

    Article  PubMed  CAS  Google Scholar 

  83. Hyland ME, Kenyon CAP, Allen RC, et al. Diary keeping in asthma: comparison of the written and electronic methods. BMJ 1993; 306: 487–9

    Article  PubMed  CAS  Google Scholar 

  84. Rand CS, Wise RA, Nides M, et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis 1992; 146: 1559–64

    PubMed  CAS  Google Scholar 

  85. Levine RJ. Monitoring for adherence: ethical considerations. Am J Respir Crit Care Med 1994; 149: 287–8

    PubMed  CAS  Google Scholar 

  86. Braunstein GL, Trinquet G, Harper AE. Compliance with nedocromil sodium and a nedocromil sodium/salbutamol. Eur Respir J 1996; 9: 893–8

    Article  PubMed  CAS  Google Scholar 

  87. van Schayck CP, van Der Heijden FM, van Den Boom G, et al. Underdiagnosis of asthma: is the doctor or the patient to blame? The DIMCA project. Thorax 2000; 55: 562–5

    Article  PubMed  Google Scholar 

  88. Siersted HC, Boldsen J, Hansen HS, et al. Population based study of risk factors for underdiagnosis of asthma in adolescence: Odense schoolchild study. BMJ 1998; 316: 651–5

    Article  PubMed  CAS  Google Scholar 

  89. Wahlström R, Lagerlov P, Stalsby Lundborg C, et al. Variations in general practitioners’ views of asthma management in four European countries. Soc Sci Med 2001; 53: 507–18

    Article  PubMed  Google Scholar 

  90. Lagerlov P, Veninga CC, Muskova M, et al. Asthma management in five European countries: doctors’ knowledge, attitudes and prescribing behaviour. Drug Education Project (DEP). Eur Respir J 2000; 15: 25–9

    PubMed  CAS  Google Scholar 

  91. Kahn LS, Fox CH, Olawaiye A, et al. Facilitating quality improvement in physician management of comorbid chronic disease in an urban minority practice. J Natl Med Assoc 2007; 99: 377–83

    PubMed  Google Scholar 

  92. Marklund B, Tunsäter A, Bengtsson C. How often is the diagnosis bronchial asthma correct? Fam Pract 1999; 16: 112–6

    Article  PubMed  CAS  Google Scholar 

  93. Adams RJ, Wilson DH, Appleton S, et al. Underdiagnosed asthma in South Australia. Thorax 2003; 58: 846–50

    Article  PubMed  CAS  Google Scholar 

  94. Doshi DR, Weinberger MM. Long-term outcome of vocal cord dysfunction. Ann Allergy Asthma Immunol 2006; 96: 794–9

    Article  PubMed  Google Scholar 

  95. Dahlström U. Frequent non-cardiac comorbidities in patients with chronic heart failure. Eur J Heart Fail 2005; 7: 309–16

    Article  PubMed  Google Scholar 

  96. Decramer M, Selroos O. Asthma and COPD: differences and similarities. With special reference to the usefulness of budesonide/formoterol in a single inhaler (Symbicort) in both diseases. Int J Clin Pract 2005; 59: 385–98

    Article  PubMed  CAS  Google Scholar 

  97. Bellia V, Battaglia S, Catando F, et al. Aging and disability affect misdiagnosis of COPD in elderly asthmatics: the SARA study. Chest 2003; 123: 1066–72

    Article  PubMed  Google Scholar 

  98. Pinnock H, Johnson A, Young P, et al. Are doctors still failing to assess and treat asthma attacks? An audit of the management of acute attacks in a health district. Respir Med 1999; 93: 397–401

    Article  PubMed  CAS  Google Scholar 

  99. Taylor DM, Auble TE, Calhoun WJ, et al. Current outpatient management of asthma shows poor compliance with International Consensus Guidelines. Chest 1999; 116: 1638–45

    Article  PubMed  CAS  Google Scholar 

  100. Bousquet J, Knani J, Henry C, et al. Undertreatment in a nonselected population of adult patients with asthma. J Allergy Clin Immunol 1996; 98: 514–21

    Article  PubMed  CAS  Google Scholar 

  101. Cydulka RK, Emerman CL, Schreiber D, et al. Acute asthma among pregnant women presenting to the emergency department. Am J Respir Crit Care Med 1999; 160: 887–92

    PubMed  CAS  Google Scholar 

  102. Steurer-Stey C, Fletcher M, Vetter W, et al. Patient education in asthma: a survey of physicians’ knowledge of the principles and implementation of self management in practice. Swiss Med Wkly 2006; 136: 561–5

    PubMed  CAS  Google Scholar 

  103. Sarrell EM, Mandelberg A, Cohen HA, et al. Compliance of primary care doctors with asthma guidelines and related education programs: the employment factor. IMAJ 2002; 4: 403–6

    PubMed  Google Scholar 

  104. Cochrane MG, Bala MV, Downs KE, et al. Inhaled corticosteroids for asthma therapy: patient compliance, devices and inhalation technique. Chest 2000; 117: 542–50

    Article  PubMed  CAS  Google Scholar 

  105. Balsbaugh TA, Chambers CV, Diamond JJ. Asthma controller medications: what do patients want? J Asthma 1999; 36: 591–6

    Article  PubMed  CAS  Google Scholar 

  106. James PN, Anderson JB, Prior JG, et al. Patterns of drug taking in patients with chronic airflow obstruction. Postgrad Med J 1985; 61: 7–10

    Article  PubMed  CAS  Google Scholar 

  107. Jones C, Santanello NC, Boccuzzi SJ, et al. Adherence to prescribed treatment for asthma: evidence from pharmacy benefits data. J Asthma 2003; 40: 93–101

    Article  PubMed  Google Scholar 

  108. Irvine L, Crombie IK, Alder EM, et al. What predicts poor collection of medication among children with asthma? A case-control study. Eur Respir J 2002; 20: 1464–9

    Article  PubMed  CAS  Google Scholar 

  109. Mann M, Eliasson O, Patel K, et al. A comparision of the effects of bid and quid dosing on compliance with inhaled flunisolide. Chest 1992; 101: 496–9

    Article  PubMed  CAS  Google Scholar 

  110. Mann MC, Eliasson O, Patel K, et al. An evaluation of severity-modulated compliance with q.i.d. dosing of inhaled beclomethasone. Chest 1992; 102: 1342–6

    Article  PubMed  CAS  Google Scholar 

  111. Simmons MS, Nides MA, Rand CS, et al. Trends in compliance with bronchodilator inhaler use between follow-up visits in a clinical trial. Chest 1996; 109: 963–8

    Article  PubMed  CAS  Google Scholar 

  112. Nides MA, Tashkin DP, Simmons MS, et al. Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest 1993; 104: 501–7

    Article  PubMed  CAS  Google Scholar 

  113. Camargo CA, Ramachandran S, Ryskina KL, et al. Association between common asthma therapies and recurrent asthma exacerbations in children enrolled in a state Medicaid plan. Am J Health Syst Pharm 2007; 64: 1054–61

    Article  PubMed  Google Scholar 

  114. Ng TP, Lim TK, Abisheganaden J, et al. Factors associated with acute health care use in a national adult asthma management program. Ann Allergy Asthma 2006; 97: 784–93

    Article  Google Scholar 

  115. Okelo SO, Wu AW, Merriman B, et al. Are physician estimates of asthma severity less accurate in black than in white patients? J Gen Intern 2007; 22: 976–81

    Article  Google Scholar 

  116. Cochrane GM. Compliance and outcomes in patients with asthma. Drugs 1996; 52: 12–9

    Article  PubMed  Google Scholar 

  117. Milgrom H, Bender B. Nonadherence with the asthma regime. Pediatr Asthma Allergy Immunol 1997; 11: 3–8

    Article  Google Scholar 

  118. Clark NM, Partridge MR. Strengthening asthma education to enhance disease control. Chest 2002; 121: 1661–9

    Article  PubMed  Google Scholar 

  119. Halm EA, Mora P, Leventhal H. No symptoms, no asthma: the acute episodic disease belief is associated with poor self-management among inner-city adults with persistent asthma. Chest 2006; 129: 573–80

    Article  PubMed  Google Scholar 

  120. Halimi L, Vachier I, Varrin M, et al. Interference of psychological factors in difficult-to-control asthma. Respir Med 2007; 101: 154–61

    Article  PubMed  Google Scholar 

  121. Conn KM, Halterman JS, Fisher SG, et al. Parental beliefs about medications and medication adherence among urban children with asthma. Ambul Pediatr 2005; 5: 306–10

    Article  PubMed  Google Scholar 

  122. Chambers CV, Markson L, Diamond JJ, et al. Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices. Respir Med 1999; 93: 88–94

    Article  PubMed  CAS  Google Scholar 

  123. Nolte H, Nepper-Christensen S, Backer V. Unawareness and undertreatment of asthma and allergic rhinitis in a general population. Respir Med 2006; 100: 354–62

    Article  PubMed  Google Scholar 

  124. Chai SM, Tan KL, Wong JL, et al. Asthma knowledge among adult asthmatic outpatients in a tertiary care hospital. Asian Pac J Allergy Immunol 2005; 22: 81–9

    Google Scholar 

  125. Kolbe J, Vamos M, James F, et al. Assessment of practical knowledge of self-management of acute asthma. Chest 1996; 109: 86–90

    Article  PubMed  CAS  Google Scholar 

  126. Ulrik CS, Backer V, Soer-Petersen U, et al. The patient’s perspective: adherence or non-adherence to asthma controller therapy? J Asthma 2006; 43: 701–4

    Article  PubMed  Google Scholar 

  127. Prabhakaran L, Lim G, Abisheganaden J, et al. Impact of an asthma education programme on patients’ knowledge, inhaler technique and compliance to treatment. Singapore Med J 2006; 47: 225–31

    PubMed  CAS  Google Scholar 

  128. Canonica GW, Baena-Cagnani CE, Blaiss MS, et al. Unmet needs in asthma: Global Asthma Physician and Patient (GAPP) survey. Global adult findings. Allergy 2007; 62: 668–74

    Article  PubMed  CAS  Google Scholar 

  129. Moffat M, Cleland J, Molen Tvd, et al. Sup-optimal patient and physician communication in primary care consultations: its relation to severe and difficult asthma. Prim Care Respir J 2006; 15: 159–65

    Article  PubMed  Google Scholar 

  130. Vincent SD, Toelle BG, Aroni RA, et al. Exasperations of asthma: a qualitative study of patient language about worsening asthma. Med J Aust 2006; 184: 451–4

    PubMed  Google Scholar 

  131. Adams RJ, Appleton S, Wilson DH, et al. Participatory decision making, asthma action plans, and use of asthma medications: a population survey. J Asthma 2005; 42: 673–8

    Article  PubMed  Google Scholar 

  132. Corsico AG, Cazzoletti L, de Marco R, et al. Factors affecting adherence to asthma treatment in an international cohort of young and middle-aged adults. Respir Med 2007; 101: 1363–7

    Article  PubMed  Google Scholar 

  133. Janson C, de Marco R, Accordini S, et al. Changes in the use of anti-asthmatic medication in an international cohort. Eur Respir J 2005; 26: 1047–55

    Article  PubMed  CAS  Google Scholar 

  134. Sun BC, Burstin HR, Brennan TA. Predictors and outcomes of frequent emergency department users. Acad Emerg Med 2003; 10: 320–8

    Article  PubMed  Google Scholar 

  135. Valerio M, Cabana MD, White DF, et al. Understanding of asthma management Medicaid patients’ perspective. Chest 2006; 129: 594–601

    Article  PubMed  Google Scholar 

  136. Clark NM, Gong M, Brown RW, et al. Influences on childhood asthma in lowincome communities in China and the United States. J Asthma 2005; 42: 493–7

    PubMed  Google Scholar 

  137. Stingone JA, Claudio L. Disparities in the use of urgent health care services among asthmatic children. Ann Allergy Asthma Immunol 2006; 97: 244–50

    Article  PubMed  Google Scholar 

  138. Greek AA, Kieckhefer GM, Kim H, et al. Family perceptions of the usual source of care among children with asthma by race/ethnicity, language, and income. J Asthma 2006; 43: 61–9

    Article  PubMed  Google Scholar 

  139. Halm FA, Wisnivesky JP, Leventhal H. Quality and access to care among a cohort of inner-city adults with asthma: who gets guideline concordant care? Chest 2005; 128: 1943–50

    Article  PubMed  Google Scholar 

  140. Dey AN, Bloom B. Summary health statistics for US children: National Health Interview Survey, 2003. Vital Health Stat 10 2005; 223: 1–78

    PubMed  Google Scholar 

  141. Dormuth CR, Glynn RJ, Neumann P, et al. Impact of two sequential drug costsharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma. Clin Ther 2006; 28: 964–78

    Article  PubMed  Google Scholar 

  142. Garg VK, Bidani R, Rich EP, et al. Asthma patient’s knowledge, perception, and adherence to the asthma guidelines. J Asthma 2005; 42: 633–8

    Article  PubMed  Google Scholar 

  143. Backer V, Ulrik CS, Harving H, et al. Management of asthma in adults: do the patients get what they need and want? Allergy Asthma Proc 2007; 28: 375–81

    Article  PubMed  Google Scholar 

  144. Kolbe J, Vamos M, Fergusson W, et al. Differential influences on asthma self-management knowledge and self-management behaviour in acute severe asthma. Chest 1996; 110: 1463–8

    Article  PubMed  CAS  Google Scholar 

  145. Sing V, Sinha HV, Gupta R. Barriers in the management of asthma and attitudes towards complementary medicine. Respir Med 2002; 96: 835–40

    Article  Google Scholar 

  146. Gilliland FD, Islan T, Berhane K, et al. Regular smoking and asthma incidence in adolescents. Am J Respir Crit Care Med 2006; 174: 1094–100

    Article  PubMed  Google Scholar 

  147. Gillissen A, Lecheler J. Social impact of asthma: patients opinion and physicians view [abstract]. Am J Respir Crit Care Med 2000; 161: A609

    Google Scholar 

  148. Gillissen A, Lecheler J. Corticophobia in adults and children with asthma: differences between patients and their physicians [abstract]. Am J Respir Crit Care Med 2000; 161: A319

    Google Scholar 

  149. Gillissen A, Lecheler J. Corticophobia in asthma [in German]. Med Klinik 2003; 98: 309–14

    Google Scholar 

  150. Boulet L-P. Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients. Chest 1998; 113: 587–92

    Article  PubMed  CAS  Google Scholar 

  151. Home R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999; 47: 555–67

    Article  Google Scholar 

  152. Grunsven van PM, Schayck van CP, Kollenburg van HJ, et al. The role of ‘fear of corticosteroids’ in nonparticipation in early intervention with inhaled corticosteroids in asthma and COPD in general practice. Eur Respir J 1998; 11: 1178–81

    Article  PubMed  Google Scholar 

  153. Irwin RS, Richardson D. Side effects with inhaled corticosteroids: the physician’s perception. Chest 2006; 130: 41–53

    Article  CAS  Google Scholar 

  154. Powell H, Gibson PG. Inhaled corticosteroid doses in asthma: an evidence-based approach. Med J Aust 2003; 178: 223–5

    PubMed  Google Scholar 

  155. Penza-Clyve SM, Mansell C, McQuaid EL. Why don’t children take their asthma medications? A qualitative analysis of children’s perspectives on adherence. J Asthma 2004; 41: 189–97

    Article  PubMed  Google Scholar 

  156. Callery P, Milnes L, Verduyn C, et al. Qualitative study of young people’s and parents’ beliefs about childhood asthma. Br J Gen Pract 2003; 53: 185–90

    PubMed  Google Scholar 

  157. Bender BG, Bender SF. Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires. Immunol Allergy Clin North Am 2005; 25: 107–30

    Article  PubMed  Google Scholar 

  158. Bender B, Milgrom H, Rand C, et al. Psychological factors associated with medication nonadherence in asthmatic children. J Asthma 1998; 35: 347–53

    Article  PubMed  CAS  Google Scholar 

  159. Creer TL, Levstek D. Medication compliance and asthma: overlooking the trees because of the forest. J Asthma 1996; 33: 203–11

    Article  PubMed  CAS  Google Scholar 

  160. Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J 2002; 19: 246–51

    Article  PubMed  CAS  Google Scholar 

  161. Walia M, Paul L, Satyavani A, et al. Assessment of inhalation technique and determinants of incorrect performance among children with asthma. Pediatr Pulmonol 2006; 41: 1082–7

    Article  PubMed  Google Scholar 

  162. Beerendonk van I, Mesters I, Mudde AN, et al. Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device. J Asthma 1998; 35: 273–9

    Article  PubMed  Google Scholar 

  163. Hesselink AE, Penninx BW, Wijnhoven HA, et al. Determinants of an incorrect inhalation technique in patients with asthma or COPD. Scand J Prim Health Care 2001; 19: 255–60

    Article  PubMed  CAS  Google Scholar 

  164. Campos A, Diaz MA, Munoz MP, et al. Assessment of the inhalation technique in asthmatic patients: a comparative study of three aerosol devices. Allergol Immunopathol (Madr) 1998; 26: 47–51

    CAS  Google Scholar 

  165. Molimard M, Raherison C, Lignot S, et al. Assessment of handling of inhaler devices in real life: an observational study in 3 811 patients in primary care. J Aerosol Med 2003; 16: 249–54

    Article  PubMed  CAS  Google Scholar 

  166. Smith A, Krishnan JA, Bilderback A, et al. Depressive symptoms and adherence to asthma therapy after hospital discharge. Chest 2006; 130: 1034–8

    Article  PubMed  Google Scholar 

  167. Nelson EC, Stason WB, Neutra RR. Identification of the noncompliant hypertensive patient. Prev Med 1980; 9: 504–17

    Article  PubMed  CAS  Google Scholar 

  168. Bosley CM, Fosbury JA, Cochrane GM. The psychological factors associated with poor compliance with treatment in asthma. Eur Respir J 1995; 8: 899–904

    PubMed  CAS  Google Scholar 

  169. Waxman HM, McCreary G, Weinrit RM, et al. A comparison of somatic complaints among depressed and non-depressed older persons. Gerontologist 1985; 25: 501–7

    Article  PubMed  CAS  Google Scholar 

  170. Bender BG. Risk-taking, depression, adherence, and symptom control in adolescents and young adults with asthma. Am J Respir Crit Care Med 2006; 173(9): 953–7

    Article  PubMed  Google Scholar 

  171. Fritz G, Rubenstein S, Lewiston N. Psychological factors in fatal childhood asthma. Am J Orthopsychiatry 1987; 57: 253–7

    Article  PubMed  CAS  Google Scholar 

  172. Kravis L. An analysis of fifteen childhood asthma fatalities. J Allergy Clin Immunol 1987; 80: 467–72

    Article  PubMed  CAS  Google Scholar 

  173. Strunk R, Mrazek DA, Wofson Fuhrmann G, et al. Physiological and psychological characteristics associated with deaths from asthma in childhood. JAMA 1985; 254: 1193–8

    Article  PubMed  CAS  Google Scholar 

  174. Laurin C, Lavoie KL, Bacon SL, et al. Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPD. Chest 2007; 132: 148–55

    Article  PubMed  Google Scholar 

  175. Hynninen KM, Breitve MH, Wibourg AB, et al. Psychological characteristics of patients with chronic obstructive pulmonary disease: a review. J Psychosom Res 2005; 59: 429–43

    Article  PubMed  Google Scholar 

  176. Bosley CM, Corden ZM, Rees PJ, et al. Psychological factors associated with use of home nebulized therapy for COPD. Eur Respir J 1996; 9: 2346–50

    Article  PubMed  CAS  Google Scholar 

  177. Hublet A, Bacquer De D, Boyce W, et al. Smoking in young people with asthma. J Public Health (Oxf) 2007; 29(4): 343–9

    Article  CAS  Google Scholar 

  178. Mo F, Robinson C, Choi B, et al. Analysis of prevalence, triggers, risk factors and the related socio-economic effects of childhood asthma in the Student Lung Health Survey. J Adolesc Health 2003; 15: 349–58

    Google Scholar 

  179. Gillissen A, Lecheler J. Bronchial asthma: a comparison of the doctor’s assessment and the patient’s opinion [in German]. Dtsch Med Wschr 2004; 129(10): 484–9

    Article  PubMed  CAS  Google Scholar 

  180. Wagena EJ, Knipschild PG, Huibers MJ, et al. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. Arch Intern Med 2005; 165: 2286–92

    Article  PubMed  CAS  Google Scholar 

  181. Silverman REB, Woodruff P, Clark S, et al. Cigarette smoking among asthmatic adults presenting to 64 emergency departments. Chest 2003; 123: 349–58

    Article  Google Scholar 

  182. Levine M, Iliescu ME, Margellos-Anast H, et al. The effects of cocaine and heroin use on intubation rates and hospital utilization in patients with acute asthma exacerbations. Chest 2005; 128: 1951–7

    Article  PubMed  Google Scholar 

  183. Partridge MR, Hill SR. Enhancing care for people with asthma: the role of communication, education, training and self-management. Eur Respir J 2000; 16: 333–48

    Article  PubMed  CAS  Google Scholar 

  184. Bender BG. Overcoming barriers to nonadherence in asthma treatment. J Allergy Clin Immunol 2002; 109: S554–9

    Article  PubMed  Google Scholar 

  185. Jones KG, Bell J, Fehrenbach C, et al. Understanding patient perceptions of asthma: results of the Asthma Control and Expectations (ACE) survey. Int J Clin Pract 2002; 56: 89–93

    PubMed  Google Scholar 

  186. Price D, Ryan D. The AIR study: asthma in real life. Asthma J 1999; 4: 74–8

    Google Scholar 

  187. Clark NM, Gong M, Schork MA, et al. Impact of education for physicians on patient outcomes. Pediatrics 1998; 101: 831–6

    Article  PubMed  CAS  Google Scholar 

  188. Cabana MD, Rand CS, Wu AW, et al. Why don’t patients follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282: 1458–65

    Article  PubMed  CAS  Google Scholar 

  189. Cabana MD, Slish KK, Evans D, et al. Impact of physician asthma care education on patient outcomes. Pediatrics 2006; 117: 2149–57

    Article  PubMed  Google Scholar 

  190. Davis RS, Bukstein DA, Luskin AT, et al. Changing physician prescribing patterns through problem-based learning: an interactive, teleconference case-based education program and review of problem-based learning. Ann Allergy Asthma Immunol 2004; 93: 237–42

    Article  PubMed  Google Scholar 

  191. Ting S. Multi-colored simplified asthma guideline reminder: why pragmatic asthma tools are needed in real-world practice. Clin Rev Allergy Immunol 2004; 27: 133–45

    Article  PubMed  Google Scholar 

  192. Carlton BG, Lucas DO, Ellis EF, et al. The status of asthma control and asthma prescribing practices in the United States: results of a large prospective asthma control survey of primary care practices. J Asthma 2005; 42: 529–35

    PubMed  Google Scholar 

  193. Coleman CI, Reddy P, Laster-Bradley NM, et al. Effect of practitioner education on adherence to asthma treatment guidelines. Ann Pharmacother 2003; 37: 956–61

    Article  PubMed  Google Scholar 

  194. Andersen M, Kragstrup J, Sondergaard J. How conducting a clinical trial affects physician’s guideline adherence and drug preferences. JAMA 2006; 295: 2759–64

    Article  PubMed  CAS  Google Scholar 

  195. Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990; 150: 1881–4

    Article  PubMed  CAS  Google Scholar 

  196. Stoloff SW, Stempel DA, Meyer J, et al. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J Allergy Clin Immunol 2004; 113: 245–51

    Article  PubMed  Google Scholar 

  197. Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients’ compliance with prescribed oral and inhaled asthma medications. Arch Int Med 1994; 154: 1349–52

    Article  CAS  Google Scholar 

  198. Bosley CM, Parry OT, Cochrane GM. Patient compliance with inhaled medication: does combining beta-agonists with corticosteroids improve compliance? Eur Respir J 1994; 7: 504–9

    Article  PubMed  CAS  Google Scholar 

  199. Sherman J, Hutson A, Baumstein S, et al. Telephoning the patient’s pharmacy to assess adherence with asthma medications by measuring refill rate for prescriptions. J Pediatr 2000; 136: 532–6

    Article  PubMed  CAS  Google Scholar 

  200. Carter EB, Ananthakrishnan M. Adherence to montelukast versus inhaled corticosteroids in children with asthma. Pediatr Pulmonol 2003; 36: 301–4

    Article  PubMed  Google Scholar 

  201. Sherman J, Patel P, Hutson A, et al. Adherence to oral montelukast and inhaled fluticasone in children with persistent asthma. Pharmacotherapy 2001; 21: 1464–7

    Article  PubMed  CAS  Google Scholar 

  202. Tremblay M, Gervais A, Lacroix C, et al. Physicians taking action against smoking: an intervention program to optimize smoking cessation counselling by Montreal general practitioners. CMAJ 2001; 165: 601–7

    PubMed  CAS  Google Scholar 

  203. Kripalani S, Yao X, Haynes B. Interventions to enhance medication adherence in chronic medical conditions. Arch Int Med 2007; 167: 540–50

    Article  Google Scholar 

  204. Sudre P, Jacquemet S, Uldry C, et al. Objectives, methods and content of patient education programmes for adults with asthma: systematic review of studies published between 1979 and 1998. Thorax 1999; 54: 681–7

    Article  PubMed  CAS  Google Scholar 

  205. Haynes RB, McDonald H, Garg AX. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2002; (2): CD000011

  206. Cote J, Bowie DM, Robichaud P, et al. Evaluation of two different educational interventions for adult patients consulting with an acute asthma exacerbation. Am J Respir Crit Care Med 2001; 163: 1415–9

    PubMed  CAS  Google Scholar 

  207. Gallefoss F, Bakke PS. How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication? Am J Respir Crit Care Med 1999; 160: 2000–5

    PubMed  CAS  Google Scholar 

  208. Smeele IJ, Grol RP, Schayck van CP, et al. Can small group education and peer review improve care for patients with asthma/chronic obstructive pulmonary disease? Quality Health Care 1999; 8: 92–8

    Article  CAS  Google Scholar 

  209. Morice AH, Wrench C. The role of the asthma nurse in treatment compliance and self-management following hospital admission. Respir Med 2001; 95: 851–6

    Article  PubMed  CAS  Google Scholar 

  210. Levy ML, Robb M, Allen J, et al. A randomized controlled evaluation of specialist nurse education following accident and emergency department attendance for acute asthma. Respir Med 2000; 94: 900–8

    Article  PubMed  CAS  Google Scholar 

  211. Schaffer SD, Tian L. Promoting adherence: effects of theory-based asthma education. Clin Nurs Res 2004; 13: 69–89

    Article  PubMed  Google Scholar 

  212. Es van SM, Nagelkerke AF, Colland VT, et al. An intervention programme using the ASE-model aimed at enhancing adherence in adolescents with asthma. Patient Educ Couns 2001; 44: 193–203

    Article  PubMed  Google Scholar 

  213. Ruoff G. Effects of flow sheet implementation on physician performance in the management of asthmatic patients. Farn Med 2002; 34: 514–7

    Google Scholar 

  214. Bender B, Milgrom H, Apter A. Adherence intervention research: what have we learned and what do we do next? J Allergy Clin Immunol 2003; 112: 489–94

    Article  PubMed  Google Scholar 

  215. Apter AJ, Boston RC, George M, et al. Modifiable barriers to adherence to inhaled steroids among adults with asthma: it’s not just black and white. J Allergy Clin Immunol 2003; 111: 1219–26

    Article  PubMed  Google Scholar 

  216. Gebert N, Hummeling R, Konning J, et al. Efficacy of a self-management program for childhood asthma: a prospective controlled study. Patient Educ Couns 1998; 35: 213–20

    Article  PubMed  CAS  Google Scholar 

  217. Bailey WC, Richards Jr JM, Brooks CM, et al. A randomized trial to improve self-management practices of adults with asthma. Arch Intern Med 1990; 150: 1664–8

    Article  PubMed  CAS  Google Scholar 

  218. Ignacio-Garcia J-M, Pinto-Tenorio M, Chocrón-Giraldez MJ, et al. Benefits of 3 yrs of an asthma education programme coupled with regular reinforcement. Eur Respir J 2002; 20: 1095–101

    Article  PubMed  CAS  Google Scholar 

  219. Cote J, Cartier A, Robichaud P, et al. Influence on asthma morbidity of asthma education programs based on self-management plans following treatment optimization. Am J Respir Crit Care Med 1997; 155: 1509–14

    PubMed  CAS  Google Scholar 

  220. Farber HJ, Oliveria L. Trial of asthma education program in an inner-city pediatric emergency department. Pediatr Asthma Allergy Immunol 2004; 17: 107–15

    Article  Google Scholar 

  221. Klein JJ, Van der Palen J, Uil SM, et al. Benefit from the inclusion of self-treatment guidelines to a self-management programme for adults with asthma. Eur Respir J 2001; 17: 386–94

    Article  PubMed  CAS  Google Scholar 

  222. Weinberger M, Murray MD, Marrero DG, et al. Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. JAMA 2002; 288: 1594–602

    Article  PubMed  Google Scholar 

  223. Song WS, Mullon J, Regan NA, et al. Instruction of hospitalized patients by respiratory therapist on metered-dose inhaler use leads to decrease in patient errors. Respir Care 2005; 50: 1040–5

    PubMed  Google Scholar 

  224. Van der Palen J, Klein JJ, Kerkhoff AH, et al. Inhalation technique of 166 adult asthmatics prior to and following a self-management program. J Asthma 1999; 36: 441–7

    Article  PubMed  Google Scholar 

  225. Thompson J, Irvine T, Grathwohl K, et al. Misuse of metered-dose inhalers in hospitalized patients. Chest 1994; 105: 715–7

    Article  PubMed  CAS  Google Scholar 

  226. Dolovich M. New propellant-free technologies under investigation. J Aerosol Med 1999; 12: S9–17

    Article  PubMed  Google Scholar 

  227. Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines. American Chest Physicians/American College of Asthma. Chest 2005; 127: 335–71

    Article  PubMed  Google Scholar 

  228. Milgrom H, Bender B, Ackerson LM, et al. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996; 98: 1051–7

    Article  PubMed  CAS  Google Scholar 

  229. Palen van der J, Klein JJ, Herwaarden van CLA, et al. Multiple inhalers confuse asthma patients. Eur Respir J 1999; 14: 1037

    Google Scholar 

  230. Stempel DA, Riedel AA, Carranza Rosenzweig JR. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma. Curr Med Res Opin 2006; 22: 463–70

    Article  PubMed  CAS  Google Scholar 

  231. Calverley PMA, Pauwels RA, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003; 361: 449–56

    Article  PubMed  CAS  Google Scholar 

  232. Calverley PMA, Pauwels RA, Vestbo J, et al. Salmeterol/fluticasone propionate combination for one year provides greater clinical benefit than its individual components in COPD [abstract]. Am J Respir Crit Care Med 2002; 165: A226

    Google Scholar 

  233. Aubier M, Wettenger R, Gans SJM. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 μg day) versus HFA-fluticasone Propionate (1000 μg day) in patients with asthma. Respir Med 2001; 95: 212–20

    Article  PubMed  CAS  Google Scholar 

  234. Aubier M, Pieters WR, Schlosser NJ, et al. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma. Respir Med 1999; 93: 876–84

    Article  PubMed  CAS  Google Scholar 

  235. Dal Negro RW, Pomari C, Tognella S, et al. Salmeterol and fluticasone 50μg/250μg bid in combination provides a better long-term control than salmeterol 50μg bid alone and placebo in COPD patients already treated with theophylline. Pulm Pharmacol Ther 2003; 16: 241–6

    Article  CAS  Google Scholar 

  236. Papi A, Canonica GW, Maestrelli P, et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med 2007; 356: 2040–52

    Article  PubMed  CAS  Google Scholar 

  237. Papi A, Paggiaro P, Nicolini G, et al. Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma. Eur Respir J 2007; 29: 682–9

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

No sources of funding were used to assist in the preparation of this review. Dr Gillissen has previously acted as a consultant for GlaxoSmithKline, AstraZeneca, and Merck Frost; has received honoraria from AstraZeneca, Asche Chiesi, Merck Frost, and GlaxoSmithKline; and has received grants from AstraZeneca and Merck Frost. Dr Wirtz has acted as a consultant for Altana Pharma and has received honoraria from Altana Pharma, AstraZeneca, GlaxoSmithKline, Merck Sharp & Dohme, and Norvartis; and Dr Juergens has received honoraria from Merck Sharp & Dohme and GlaxoSmithKline.

Author’s website: http://www.rkk-leipzig.de

Author information

Authors and Affiliations

  1. St. George Medical Center, Robert-Koch-Hospital, Nikolai-Rumjanzew-Str. 100, Leipzig, D-04702, Germany

    Adrian Gillissen (head of the Robert-Koch-Hospital)

  2. Department of Pulmonary Medicine, University Hospital, Leipzig, Germany

    Hubertus Wirtz

  3. University Hospital Bonn, Bonn, Germany

    Uwe Juergens

Authors
  1. Adrian Gillissen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hubertus Wirtz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Uwe Juergens
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gillissen, A., Wirtz, H. & Juergens, U. Patient and Physician Factors Contributing to Poor Outcomes in Patients with Asthma and COPD. Dis-Manage-Health-Outcomes 15, 355–376 (2007). https://doi.org/10.2165/00115677-200715060-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-200715060-00004

Keywords

Search

Navigation